Dr. Irit Van-Ham holds a Ph.D. in Pharmacology and has extensive experience in formulation development and toxicology, having worked with Teva Pharmaceuticals and the Canadian Ministry of Health. As the Chief Technology Officer and Co-Founder of ToeFX Inc., Dr. Van-Ham leads the development of innovative solutions for onychomycosis, including the ToeFX photodisinfection system and PCR-based diagnostics.
Passionate about bridging science and clinical foot care, she plays a major role in diagnostic testing and treatment development for onychomycosis. Outside of her professional work, Dr. Van-Ham enjoys cooking and cycling and hiking often accompanied by her dog.